AbbVie Inc. (ABBV) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は North Chicago, IL, アメリカ. 現CEOは Scott T. Reents.
ABBV を有する IPO日 2013-01-02, 55,000 名の正社員, に上場 NYSE, 時価総額 $372.01B.
AbbVie Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a diverse portfolio of medicines across multiple therapeutic areas. The company's key products include HUMIRA for autoimmune diseases, SKYRIZI for psoriasis, RINVOQ for rheumatoid arthritis, IMBRUVICA and VENCLEXTA for blood cancers, and MAVYRET for hepatitis C, along with established brands such as Synthroid for hypothyroidism, Botox, Lupron, and Linzess for gastrointestinal conditions. AbbVie also offers specialized treatments in ophthalmology, neurology, and women's health, including eye care solutions and migraine therapies. Headquartered in North Chicago, Illinois, and incorporated in 2012, the company maintains research collaborations to advance its drug pipeline and expand its global reach.
